Compound repurposing
Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.
PBS buffer with Tween 20 (20x) (HB8088)
Description:20x wash buffer for use during immunolabeling techniques such as IHC.
-
TBS-T with Tween 20 (20x) (HB6971)
Description:20x Tris Buffered Saline wash buffer to remove non-specific binding and for use during immunolabeling techniques such as IHC.
- Description:
Neurotoxin, widely used to produce the 6-OHDA Parkinson’s disease model
Purity:>98%
-
(+)-Abscisic acid (HB4674)
Description:Phytohormone and endogenous lanthionine synthetase C-like 2 (LANCL2) ligand
Purity:>99%
-
-
β-Amyloid Peptide (1-42) (human) (HB9805)
Description:β-Amyloid (1-42) protein fragment. Implicated in Alzheimer's disease.
-
-
